Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$572M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$495M |
| 3 |
iShares MBS ETF
MBB
|
+$405M |
| 4 |
Procter & Gamble
PG
|
+$365M |
| 5 |
Microsoft
MSFT
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$605M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$544M |
| 3 |
Sempra
SRE
|
+$474M |
| 4 |
CELG
Celgene Corp
CELG
|
+$411M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$380M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.85% |
| 2 | Healthcare | 5.77% |
| 3 | Financials | 5.26% |
| 4 | Consumer Discretionary | 4.71% |
| 5 | Communication Services | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
INFN
4576
CALL
DELISTED
Infinera Corporation Common Stock
INFN
| $323K | ﹤0.01% |
40,700
+7,500
| +23% | +$46.1K |
|
4577
Northrim BanCorp
NRIM
$606M
| $322K | ﹤0.01% |
33,628
+20,104
| +149% | +$192K |
|
|
TEN
4578
CALL
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $322K | ﹤0.01% |
24,600
+18,500
| +303% | +$243K |
|
|
STXB
4579
DELISTED
Spirit of Texas Bancshares, Inc. Common Stock
STXB
| $322K | ﹤0.01% |
14,004
+7,176
| +105% | +$158K |
|
|
SOHU
4580
PUT
Sohu.com
SOHU
$365M
| $321K | ﹤0.01% |
28,700
-7,000
| -20% | -$73.3K |
|
|
LGF.A
4581
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $321K | ﹤0.01% |
30,129
+21,879
| +265% | +$202K |
|
4582
Clean Energy Fuels
CLNE
$418M
| $320K | ﹤0.01% |
136,938
+19,504
| +17% | +$41.4K |
|
|
VSLR
4583
DELISTED
VIVINT SOLAR, INC.
VSLR
| $320K | ﹤0.01% |
44,131
+22,410
| +103% | +$158K |
|
|
BHR
4584
Braemar Hotels & Resorts
BHR
$146M
| $319K | ﹤0.01% |
35,795
+20,023
| +127% | +$187K |
|
|
CTO
4585
CTO Realty Growth
CTO
$813M
| $319K | ﹤0.01% |
19,492
+6,893
| +55% | +$119K |
|
4586
CALL
Welltower
WELL
$164B
| $319K | ﹤0.01% |
3,900
-16,400
| -81% | -$1.4M |
|
4587
Willdan Group
WLDN
$1.15B
| $319K | ﹤0.01% |
10,051
+4,999
| +99% | +$158K |
|
|
MDR
4588
DELISTED
McDermott International
MDR
| $319K | ﹤0.01% |
471,335
-1,387,456
| -75% | -$1.77M |
|
4589
CALL
AMC Entertainment Holdings
AMC
$2.37B
| $318K | ﹤0.01% |
+4,390
| New | +$386K |
|
4590
Clarus
CLAR
$128M
| $318K | ﹤0.01% |
23,555
+11,864
| +101% | +$146K |
|
|
CRON
4591
Cronos Group
CRON
$1.04B
| $318K | ﹤0.01% |
41,471
+25,903
| +166% | +$198K |
|
4592
Greif Class B
GEF.B
$4.12B
| $318K | ﹤0.01% |
6,141
+3,084
| +101% | +$153K |
|
4593
PUT
ProShares Ultra Technology
ROM
$1.27B
| $318K | ﹤0.01% |
16,000
-800
| -5% | -$14K |
|
|
FRTA
4594
DELISTED
Forterra, Inc
FRTA
| $318K | ﹤0.01% |
27,577
+8,291
| +43% | +$80.6K |
|
4595
Business First Bancshares
BFST
$1.05B
| $317K | ﹤0.01% |
12,717
+6,331
| +99% | +$155K |
|
|
BBBY
4596
PUT
Bed Bath & Beyond
BBBY
$541M
| $317K | ﹤0.01% |
59,762
-265,002
| -82% | -$1.77M |
|
4597
CB Financial Services
CBFV
$190M
| $317K | ﹤0.01% |
10,507
-480
| -4% | -$13.6K |
|
4598
Cue Biopharma
CUE
$113M
| $317K | ﹤0.01% |
665
+190
| +40% | +$59.7K |
|
4599
Quanterix
QTRX
$174M
| $317K | ﹤0.01% |
13,433
-21,881
| -62% | -$499K |
|
|
CALA
4600
DELISTED
Calithera Biosciences, Inc
CALA
| $316K | ﹤0.01% |
2,771
+590
| +27% | +$44.4K |
|
Similar funds
Barclays's Q4 2019 Portfolio in Review
As of Q4 2019, Barclays held 7,254 positions worth $180B, up 13% from $160B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays deployed $6.1B of net new capital in Q4 2019, opening 260 new positions and adding to 3,541 existing holdings. Its largest new stake was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $605M trimmed.
- Barclays's largest Q4 2019 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
- Barclays added most to Apple in Q4 2019, an estimated $572M increase.
- Barclays's biggest Q4 2019 reduction was Invesco QQQ Trust, cutting an estimated $605M.
- Barclays fully exited Celgene Corp in Q4 2019, selling an estimated $411M.
- Barclays's ten largest holdings make up 26% of its $180B portfolio in Q4 2019.
- Barclays opened 260 new positions and closed 700 in Q4 2019.
- Barclays's portfolio value rose 13% quarter-over-quarter to $180B.
Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.